Literature DB >> 28286946

Reversible Redox Cycling of Well-Defined, Ultrasmall Cu/Cu2O Nanoparticles.

Sebastian D Pike1, Edward R White1, Anna Regoutz2, Nicholas Sammy1, David J Payne2, Charlotte K Williams3, Milo S P Shaffer1,2.   

Abstract

Exceptionally small and well-defined copper (Cu) and cuprite (Cu2O) nanoparticles (NPs) are synthesized by the reaction of mesitylcopper(I) with either H2 or air, respectively. In the presence of substoichiometric quantities of ligands, namely, stearic or di(octyl)phosphinic acid (0.1-0.2 equiv vs Cu), ultrasmall nanoparticles are prepared with diameters as low as ∼2 nm, soluble in a range of solvents. The solutions of Cu NPs undergo quantitative oxidation, on exposure to air, to form Cu2O NPs. The Cu2O NPs can be reduced back to Cu(0) NPs using accessible temperatures and low pressures of hydrogen (135 °C, 3 bar H2). This striking reversible redox cycling of the discrete, solubilized Cu/Cu(I) colloids was successfully repeated over 10 cycles, representing 19 separate reactions. The ligands influence the evolution of both composition and size of the nanoparticles, during synthesis and redox cycling, as explored in detail using vacuum-transfer aberration-corrected transmission electron microscopy, X-ray photoelectron spectroscopy, and visible spectroscopy.

Entities:  

Keywords:  copper nanoparticles; copper(I) oxide nanoparticles; organo-copper(I); redox switching; transmission electron microscopy; ultrasmall nanoparticles

Year:  2017        PMID: 28286946     DOI: 10.1021/acsnano.6b07694

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  1 in total

1.  HKUST-1 derived Cu@CuO x /carbon catalyst for base-free aerobic oxidative coupling of benzophenone imine: high catalytic efficiency and excellent regeneration performance.

Authors:  Huang Kaimeng; Chen Siyuan; Xia Changjiu; Li Chenhao; Zhu Bin; Gao Hongyi; Peng Xinxin; Lin Min; Luo Yibin; Wang Ge; Shu Xingtian
Journal:  RSC Adv       Date:  2020-10-01       Impact factor: 4.036

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.